We catch up with researchers Jeff Holt and Karen Avraham about the state of gene therapy for addressing hearing loss and deafness. Both are part of the Research Symposium on Hearing at the 2024 ASHA Convention.Our guests explain what recent breakthroughs, including successful clinical trials, mean for the future of gene therapy. They comment on audiologists' potential role in treatment and assessment related to gene therapy.You can learn more about gene therapy and hearing loss at the Research Symposium on Hearing at the 2024 ASHA Convention in Seattle this December.Learn More:Research Symposium on Hearing (https://www.asha.org/research/research-symposium-on-hearing/)ASHA Voices: Revisiting Conversations on Gene Therapy and Hearing Loss (https://leader.pubs.asha.org/do/10.1044/2022-0303-podcast-gene-therapy-one/full/)First Deaf Gene Therapy Recipient in U.S. Gains Hearing (https://leader.pubs.asha.org/do/10.1044/2024-0124-auds-gene-therapy/full/)
Podden och tillhörande omslagsbild på den här sidan tillhör American Speech-Language-Hearing Association (ASHA). Innehållet i podden är skapat av American Speech-Language-Hearing Association (ASHA) och inte av, eller tillsammans med, Poddtoppen.
